BioInfra Co.,Ltd.
Offers cancer screening blood tests and provides CRO services to the pharmaceutical industry.
199730 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 경기도 용인시 기흥구 흥덕중앙로 120 4층, 5층, 용인시
- Website:
- http://bioinfra.co.kr/?lang=en
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
BioInfra Co., Ltd. is a global healthcare and biotechnology company focused on advancing human health through innovative solutions for disease prevention and treatment. The company's core activities are centered on two primary business segments: diagnostics development and contract research organization (CRO) services. Its flagship product is a proprietary multi-biomarker blood test, a screening technology designed for the early detection of risk for eight major types of cancer. The company's CRO division provides comprehensive support to the pharmaceutical industry, offering services that include Phase 1 clinical trials, bioequivalence testing, immunoassays, and pharmaceutical quality inspections.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for BioInfra Co.,Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all BioInfra Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for BioInfra Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
